Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women

Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine. Methods: Efficacy, immunogenicity, and safety outcomes were assessed in Latin American participants enrol...

Descripción completa

Detalles Bibliográficos
Autores Principales: Ruiz-Sternberga, Ángela María, Moreira Jr, Edson D., Restrepo, Jaime A., Lazcano-Ponce, Eduardo, Cabello, Robinson, Silva, Arnaldo, Andrade, Rosires, Revollo, Francisco, Uscanga, Santos, Victoria, Alejandro, Guevara, Ana María, Luna, Joaquín, Plata, Manuel, Nossa Dominguez, Claudia, Fedrizzi, Edison, Suarez, Eugenio, Reina, Julio C., Ellison, Misoo C., Moeller, Erin, Ritter, Michael, Shields, Christine, Cashat, Miguel, Perez, Gonzalo, Luxembourg, Alain
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2018
Materias:
Acceso en línea:http://repository.urosario.edu.co/handle/10336/18762